Increased competition from lower-priced offerings in the IVF industry have seen the Virtus Health share price almost halve. More
By James Carlisle -
James Carlisle is the head of research at Intelligent Investor (under AFSL 282288), owned by InvestSMART Group Limited. James has been researching stocks for more than two decades. After qualifying as a lawyer and working as a fund manager in London, James moved to Australia in 2002 and soon found Intelligent Investor. He covers the banking and financial services sectors. To unlock Intelligent Investor stock research and buy recommendations, take out a 15-day free membership.